Editas Medicine (EDIT) Receivables (2015 - 2025)
Editas Medicine's Receivables was $15.18 million in Q4 2025, down 6.7% from $16.27 million a year earlier but up 86.7% from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Receivables (2015 - 2025) Analysis & Trends
From Q4 2015 onward, Editas Medicine has reported Receivables for 40 quarters.
- Receivables shows a five-year compound annual growth rate of 20.2% (FY2020 to FY2025).
- In earlier years, Receivables was $16.27 million in FY2024 (+59.7%), $10.19 million in FY2023 (+98.0%), $5.15 million in FY2022 and $267,000 in FY2021 (-95.6%).
- Quarterly Receivables has moved between $120,000 (Q3 2022) and $16.27 million (Q4 2024) over five years.
- Compared with a year earlier, Receivables was higher in four of the last seven quarters, with growth averaging 17.0%.
- The best year-over-year quarter for Receivables over five years was Q2 2023 (growth of 220.6%); the worst was Q4 2021 (a decline of 95.6%).
- Per Business Quant data, EDIT's Receivables in the three quarters before Q4 2025 was $8.13 million (Q3 2025), $588,000 (Q2 2025) and $510,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Editas Medicine | 222.97 Mn | -488.78 Mn | - | 15.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 15.18 Mn |
| Sep 30, 2025 | 8.13 Mn |
| Jun 30, 2025 | 588,000.00 |
| Mar 31, 2025 | 510,000.00 |
| Dec 31, 2024 | 16.27 Mn |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 244,000.00 |
| Mar 31, 2024 | 245,000.00 |
| Dec 31, 2023 | 10.19 Mn |
| Sep 30, 2023 | 2.42 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 242,000.00 |
| Dec 31, 2022 | 5.15 Mn |
| Sep 30, 2022 | 120,000.00 |
| Jun 30, 2022 | 713,000.00 |
| Mar 31, 2022 | 1.37 Mn |
| Dec 31, 2021 | 267,000.00 |
| Sep 30, 2021 | 251,000.00 |
| Jun 30, 2021 | 331,000.00 |
| Mar 31, 2021 | 672,000.00 |
API Access
Editas Medicine Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();